What is the prevalence of Kaposi sarcoma (KS) in the US?

Updated: Mar 30, 2020
  • Author: Robert A Schwartz, MD, MPH; Chief Editor: Dirk M Elston, MD  more...
  • Print
Answer

The incidence of Kaposi sarcoma (KS) has been estimated at 0.02-0.06%. Traditional Kaposi sarcoma of middle-aged and older American men of Mediterranean and Eastern European (Ashkenazi) Jewish lineage represents approximately 0.2% of cancer cases in the United States. Iatrogenic Kaposi sarcoma has a 400% increased incidence compared to the American population at large. The incidence of Kaposi sarcoma among American renal transplant recipients is approximately 0.4%. In the AIDS grouping, Kaposi sarcoma originally accounted for as many as 35% of patients, an incidence that has been declining with early detection of AIDS, although Kaposi sarcoma prevalence may remain high. In the United States, a few emigrants arrive from Kaposi sarcoma–endemic regions (primarily Africa). The largest immigrant population in this category may be Haitians; however, recent evidence suggests that Haitian AIDS originated directly in New York rather than Africa.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!